Carcinoma Ovary Metastasis to Breast

Authors

  • Rajnish Nagarkar Department of Surgical Oncology, Curie Manavata Cancer Centre, Nashik, Maharashtra, India
  • Tejashree Deshpande Department of Surgical Oncology, Curie Manavata Cancer Centre, Nashik, Maharashtra, India
  • Shrikant Suryavanshi Department of Surgical Oncology, Curie Manavata Cancer Centre, Nashik, Maharashtra, India
  • Swapnali Mandlik Department of Surgical Oncology, Curie Manavata Cancer Centre, Nashik, Maharashtra, India

Keywords:

Carcinoma Ovary, metastasis, breast

Abstract

Abstract

Ovarian cancer commonly metastasises to lymph nodes, lung and liver. Primary ovarian carcinoma metastasising to breast is a very unusual and very few cases are described. Literature reports only 39 cases till date. Most common histological variety of Primary ovarian cancer metastasising to breast is papillary serous adenocarcinoma. Metastasis to breast suggests distant spread of the tumour and hence poor prognosis with median age of survival being 6 months from the date of diagnosis of breast metastasis. Although metastasis of ovarian carcinoma to breast is rare there should always be high index of suspicion during follow up of patient with ovarian cancer. Differentiation between primary and metastatic cancer of breast is important as treatment plan changes completely. We report a case of 60 year old female patient of papillary serous adenocarcinoma of ovary metastasising to breast. Patient developed breast metastasis after 1 year of completion of treatment for primary ovarian cancer. Her histopathology was suggestive of adenocarcinoma with immunohistochemistry positive for metastatic ovarian carcinoma. She was started on chemotherapeutic agents but died of disseminated disease within one year of initiation of treatment.

Keywords: Carcinoma ovary, metastasis, breast, adenocarcinoma, prognosis

Cite this Article

Rajnish Nagarkar, Tejashree Deshpande, Shrikant Suryavanshi et al. Carcinoma Ovary Metastasis to Breast. Research & Reviews: Journal of Oncology & Hematology. 2016; 5(2): 6–10p.


 

Downloads

Published

2016-08-23

Issue

Vol. 5 No. 2 (2016)

Section

Case Study

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is notpublished already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  • I/We also agree to the authorship of the article in the following order:

Author’s name

 

1. ________________

2. ________________

3. ________________

_______________

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.